Recent Updates
Recently added Catalysts
HSIC Positive Sentiment

Henry Schein Announces Chief Financial Officer Leadership Transition

Thursday, October 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Henry Schein, Inc. has appointed Emmanuel Caprais as the new Senior Vice President and Chief Financial Officer, effective November 4, 2026. Caprais, who previously served at ITT, Inc., will report to CEO Frederick M. Lowery. This transition is part of a structured plan to enhance the company's financial leadership.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emmanuel Caprais brings extensive experience from ITT, Inc.
  • Leadership transition aims to strengthen financial oversight.
  • Caprais will join the Henry Schein Leadership Team.

Full Press Release Details

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Emmanuel Caprais, former Senior Vice President and Chief Financial Officer of ITT, Inc. (NYSE: ITT), has been named the Company’s Senior Vice President and Chief Financial Officer effective November 4, 2026. Mr. Caprais will join the Henry Schein Leadership Team (HSLT) and report to Frederick M. Lowery, Chief Executive Officer of Henry Schein. To support a structured transition, Mr. Caprais will initially se

Frequently Asked Questions

Who is the new CFO of Henry Schein?

Emmanuel Caprais has been named the new CFO of Henry Schein.

When will Emmanuel Caprais start his role?

He will assume the role of CFO effective November 4, 2026.

What was Emmanuel Caprais's previous position?

He was the Senior Vice President and CFO at ITT, Inc.

Who will Caprais report to at Henry Schein?

He will report to Frederick M. Lowery, the CEO of Henry Schein.

ShareAdd on Google
Tags: HSIC Henry Schein CFO Emmanuel Caprais leadership change financial oversight
Last updated: Oct 8, 2026

Biotech snapshot

Cash runway
$157M liquidity · $0M/mo burn
Low dilution risk